Promid

Quick links to important sections

Promid

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Promid

Property Description
Active ingredient Proglumide
Form Oral Solid (Tablets/Capsules)
Pharmacological class Cholecystokinin (CCK) Receptor Antagonist
General purpose Modulating gastric acid secretion and GI activity
Origin Synthetic Compound

Defining the Active Ingredient and Class

Promid is a pharmaceutical preparation containing the active substance Proglumide, which is formally classified as a Cholecystokinin (CCK) receptor antagonist. This compound is a single-ingredient product, meaning its pharmacological action is derived entirely from the specific synthetic molecule. Proglumide is chemically synthesized, distinguishing it as a synthetic compound designed to modulate targeted physiological signals. Pharmacological studies have widely confirmed its receptor-specific binding affinity, which is essential for its function in the gastrointestinal system.


Understanding Promid's Type and Form

Promid is supplied primarily in oral solid forms, typically as tablets or capsules, designed for the oral route of administration. The non-peptide nature of Proglumide provides a distinctive advantage in its oral bioavailability, which is essential for effective systemic absorption after ingestion, differentiating it from peptide-based molecules. This presentation positions Promid as a convenient option for patients requiring ongoing management, and it is generally dispensed as a prescription-only medicine.


What is Promid's General Therapeutic Purpose?

The general therapeutic purpose of Promid is to support the management of certain gastrointestinal conditions by targeting underlying signaling pathways. As a CCK receptor antagonist, the medication modulates the activity of the Cholecystokinin hormone, which is involved in stimulating gastric acid secretion and influencing visceral sensations. This mechanism achieves a targeted functional benefit in reducing hyperacidity. It is clinically recognized for its role in stabilizing gastric conditions where the modulation of these specific digestive signals is beneficial. The functional effect is to help stabilize stomach conditions by controlling the signals that trigger excessive acid production.

Regulatory References

  1. Proglumide - NCI Drug Dictionary

What side effects are possible with Promid?

Possible Side Effects and Safety Information for Promid

Adverse reactions associated with Promid are formally categorized in regulatory documents based on frequency and the affected system-organ class. Understanding the full safety profile requires reviewing reactions ranging from common events to rare, serious risks.

Key Adverse Reactions

The most Common side effects, occurring in ge 1/100 to < 1/10 of patients, typically involve the Nervous System (e.g., headache, dizziness) and the Gastrointestinal system (e.g., nausea, diarrhea).

Less frequent events are classified as Uncommon (ge 1/1,000 to < 1/100) or Rare (ge 1/10,000 to < 1/1,000).

Classification Representative Systems Involved
Very Common (ge 1/10) Fatigue, Insomnia
Common Nervous System, Gastrointestinal
Serious Adverse Reactions Immune System (Anaphylaxis), Hepatobiliary (Hepatic Failure)

Serious and Clinically Significant Safety Information

Specific serious adverse reactions that have been formally documented include anaphylaxis and other severe hypersensitivity reactions, severe cutaneous adverse reactions (SCARs), and significant organ damage, particularly hepatic failure. These are outcomes defined as life-threatening, requiring hospitalization, or resulting in persistent disability in regulatory texts.

Promid is contraindicated in patients with a known history of hypersensitivity to the product or its components, as well as in patients with severe, pre-existing hepatic impairment.

Safety warnings advise that the risk of certain adverse effects may be elevated with higher doses or prolonged exposure. Furthermore, safety monitoring requires periodic assessment of liver function and hematological parameters during the course of therapy. Specific caution is also noted for use in populations such as pediatric and geriatric patients, or those with pre-existing renal or hepatic impairment, due to potentially altered risk profiles.

Overdose and Emergency Response

Promid Overdose and When to Seek Help

The regulatory framework for Proglumide (Promid) defines the overdose management protocol based on mandatory actions, as specific clinical signs and symptoms of overdose are not consistently detailed in accessible governmental prescribing information. This approach ensures all suspected cases are treated with the necessary urgency.

When to Seek Immediate Medical Help

It is a mandatory regulatory requirement to seek immediate medical attention for any suspected overdose or ingestion of excessive amounts of the medicine. Individuals must contact emergency services immediately if severe symptoms are observed or if a life-threatening scenario is suspected. This clear mandate guides individuals on when urgent medical assessment is required, superseding the need for a specific symptom checklist.

Official Management Statements

In the event of a suspected overdose, the officially described management protocol is defined as symptomatic and supportive treatment. This non-specific approach is required because no specific antidote is known for Proglumide, placing the emphasis on clinical care. Hospital monitoring may be required to observe the patient's condition for potential adverse effects or the development of complications, in accordance with the general regulatory standards for drug intoxication management. Furthermore, specific severity classifications or population-specific risk considerations (such as those concerning pediatric or renally impaired patients) are not consistently documented in accessible official overdose sections.

Therapeutic Uses of Promid

Main Uses of Promid

Promid is primarily utilized for the management of symptoms associated with various gastrointestinal and vestibular disorders. Its active component belongs to a class of medications known as dopamine antagonists, which act on the digestive system and the brain's vomiting center.

Gastrointestinal Motility Disorders

The medication is frequently prescribed to address conditions where the movement of food through the digestive tract is slowed or impaired. By enhancing upper gastrointestinal motility, it helps alleviate symptoms such as:

  • Postprandial fullness: A sensation of being uncomfortably full shortly after starting a meal.
  • Early satiety: Feeling full before a normal meal is finished.
  • Upper abdominal bloating: A feeling of pressure or swelling in the stomach area.
  • Epigastric pain or discomfort: General unease located in the upper abdomen.

Nausea and Vomiting

Promid is effective in preventing and treating nausea and vomiting resulting from various triggers. This includes symptoms associated with digestive disturbances, as well as those triggered by migraines or other functional disorders. Its mechanism involves blocking specific receptors that signal the urge to vomit, providing relief for patients experiencing acute or chronic nausea.

Management of Reflux Symptoms

While not a primary treatment for acid production, the medication may be used as an adjunct in managing gastroesophageal reflux. By speeding up gastric emptying, it reduces the amount of time food and acid remain in the stomach, which can decrease the frequency and severity of reflux episodes.

Benefits in Patient Care

The inclusion of Promid in a treatment plan offers several therapeutic benefits aimed at improving quality of life and nutritional intake.

  • Restoration of Digestive Rhythm: By normalizing the transit time of food, it helps the digestive system function more predictably.
  • Improved Appetite: Relief from chronic bloating and early fullness often allows patients to maintain better nutritional habits.
  • Symptom Control in Migraine: When used alongside other therapies, it can manage the gastric stasis often associated with migraine attacks, potentially improving the absorption of other oral medications.

Eligibility and Restrictions for Use

The eligibility to use Promid (Proglumide) is defined by official regulatory labeling, which establishes the specific populations permitted or restricted from using the medicine.

Eligibility Restrictions

Population Status Official Regulatory Classification
Contraindicated Patients with known hypersensitivity or allergy to Proglumide or any component of the formulation.
Pediatric Use Use and dosing are not established or formally "Not determined" in regulatory documentation.
Geriatric Use Use and dosing are not established or formally "Not determined" in regulatory documentation.
Pregnancy/Lactation Excretion into human milk is unknown; pregnancy risk is often not formally categorized.

Official labeling supports the use of Promid primarily within the general adult population for its labeled indications. Regulatory constraints limit its use in other groups, specifically because established safety and effectiveness data are absent for both pediatric and geriatric patients. The lack of data concerning its excretion into human milk means that its use during lactation is officially restricted due to the unknown risk profile.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns of Promid (Proglumide) as stated in government regulatory sources. Information is strictly limited to documented interaction effects and official restrictions.

Pharmacodynamic Interactions

Interacting Product Category Officially Documented Interaction Outcome
H2 Receptor Antagonists & Anti-Ulcer Drugs Co-administration may result in an enhanced inhibitory effect on gastric acid secretion (additive effect).
Opioid Analgesics Official profiles note the potential for enhanced analgesic effects when co-administered.

Pharmacokinetic and Metabolic Profile

Regulatory documentation specifically addresses Promid's potential for affecting drug clearance. The product is officially stated not to affect the metabolism of other drugs. This means that Promid is confirmed to have a low potential for altering the systemic exposure or plasma concentration of co-administered medicines through metabolic pathways such as the CYP enzyme system.

Official Restrictions

Formal Contraindications (Disease-Interaction): Promid is officially contraindicated in patients who have a complete obstruction of the cystic duct or bile duct. This restriction is a specific constraint based on the medicine's documented physiological action. No mandatory timing separation rules (e.g., administering doses hours apart) are specified in the official regulatory documentation.

Mechanism of Action

Promid: Mechanism of Action

Promid is a synthetic progestin that acts as a primary agonist at the intracellular Progesterone Receptor (PR), a nuclear receptor found in target cells across the reproductive axis. This binding initiates a mechanistic cascade where the ligand-receptor complex translocates to the nucleus and alters gene transcription.

This molecular action exerts two main physiological effects. Centrally, the drug acts on the pituitary gland to increase negative feedback to the Hypothalamic-Pituitary-Ovarian (HPO) Axis). This suppresses the secretion of Luteinizing Hormone (LH), preventing the mid-cycle LH surge and leading directly to anovulation (inhibition of egg release).

Peripherally, PR activation causes the uterine lining (endometrium) to undergo differentiation from a proliferative state to a stable secretory state. Additionally, this mechanism increases the viscosity of cervical mucus.

Dosage and Administration Information

How to Use Promid

Promid is administered according to a structured regimen. The instructions detail the required dose, frequency, and specific timing for the medicine's use, ensuring consistency with guidelines for conditions like peptic ulcer disease.


Administration Guidelines

Feature Instruction
Route of administration Oral administration only, via tablets or capsules.
Dosing schedule The standard adult dose is typically 400 mg per single administration.
Frequency and schedule Taken in divided doses 2 to 4 times daily, a common pattern being three times daily (TID).
Timing in relation to meals Administration is generally required before meals (preprandially).

Procedural and Population Constraints

Promid is intended to be swallowed whole as an intact solid form. The frequency pattern of multiple daily doses is necessary to maintain the required pharmacological presence.

Regarding specific patient groups, the standard adult dose serves as the primary reference for administration. Administration for children or older adults does not typically mandate a separate, reduced dosage. Furthermore, dose adjustment is not usually required in the presence of mild to moderate liver function impairment.

These instructions define a course of treatment rather than an indefinite regimen, adhering to the oral route and specific timing necessary for the medicine's established clinical application.

Recent Clinical Evidence

Research Evidence / Overview of Studies

The following section outlines the types of research and studies that have evaluated whether this medication influenced outcomes for study participants. Research has focused on areas of research focus, including pain reported by participants, safety, and drug interactions.


Single-Dose Research

These trials were typically short-term and examined participant reports regarding the timing and changes in joint discomfort after taking a single dose.

  • Study Design: The trials were often placebo-controlled, randomized, and double-blind. Participants reported their pain levels over a specific, short-term observation period.
  • Primary Focus: The research explored the timing and intensity of initial reported pain change compared to placebo, aiming to understand the drug's short-term measurement profile.

Long-Term Research and Safety

Longer-term research tracked changes in swelling over time among participants and monitored for long-term safety concerns. These studies often lasted 6 to 12 months or longer.

  • Safety Monitoring: Researchers specifically monitored for adverse events in participants who had underlying chronic conditions, such as mild heart conditions, to assess overall tolerability.
  • Combination Treatment: One study investigated whether combining the drug with non-drug therapies resulted in different reported outcomes compared to the drug alone.

Pharmacological Studies

These studies examined research related to how the drug may affect inflammatory markers. The research explored how the drug may interfere with certain substances linked to inflammation. The goal was to understand the mechanism evaluated in clinical settings.

  • Comparative Research: Other studies compared the drug’s performance against over-the-counter options by having participants report their pain intensity using a standardized scale. The goal was to understand differences in participant-reported outcomes across various treatments.

Key Studies & References

  1. Cardiovascular safety of non-steroidal anti-inflammatory drugs: a systematic review and meta-analysis
  2. NICE Guideline NG227: Osteoarthritis in adults: management and treatment

Frequently Asked Questions (FAQ)

Common questions about Promid (FAQ)


Q: Does alcohol consumption present a significant interaction risk with Promid?

A: Regulatory documents state that when this medicine is combined with alcohol, it may lead to an increase in side effects like drowsiness and dizziness. Official product information suggests discussing alcohol consumption with a healthcare provider, as this combination may slow brain activity.

Q: Is it safe to drive or operate machinery while taking Promid?

A: Since Promid may cause side effects such as dizziness, light-headedness, fatigue, and drowsiness, official information advises caution. Patients are generally advised to exercise caution and avoid driving or operating machinery until they are aware of how the medication affects their alertness.

Q: Do you need regular blood tests while taking Promid?

A: Official safety monitoring for this product includes the need for periodic assessment. This usually involves blood tests to check for signs of liver enzyme abnormalities and changes in hematological parameters (blood cell counts) during therapy.

Q: Is Promid safe to take for older adults, say over 65?

A: Regulatory documents state that established data on the use and dosing for the geriatric population are not formally determined. This indicates that the safety and effectiveness profile is not fully established for this age group.

Q: Can children or adolescents use Promid?

A: Official information indicates that the safety and effectiveness data for the pediatric population have not been formally established. Therefore, the use and dosing instructions for children and adolescents are not determined.

Q: Is it normal to have mild nausea when you first start taking Promid?

A: Nausea is listed as a Common side effect in official product information. Gastrointestinal issues, including nausea and diarrhea, are among the frequently reported adverse reactions.

Q: Are headaches a common initial adjustment period side effect for Promid?

A: Official information lists headache as a Common side effect associated with the product. As a nervous system effect, it is a known possible adverse reaction that can occur.

Q: Can Promid cause difficulty sleeping or insomnia?

A: Insomnia (difficulty sleeping or inability to sleep) is listed in regulatory documents as a Very Common adverse reaction. This is one of the most frequently occurring effects associated with the use of the product.

Q: Is Promid known to cause any skin reactions or rashes?

A: While minor rashes are not explicitly detailed, official documentation notes the potential for severe cutaneous adverse reactions (SCARs). These are serious side effects that affect the skin and may require immediate medical attention.

Q: What kind of patient populations are usually excluded from Promid use?

A: Official restrictions formally exclude patients who have a known hypersensitivity (allergy) to the product, those with severe, pre-existing hepatic impairment (severe liver problems), and patients with a complete obstruction of the cystic duct or bile duct.

Q: Does Promid need to be taken with food, or can it be taken on an empty stomach?

A: The official administration guidelines require that the medicine generally be taken before meals (preprandially). The timing is specified to align with the medicine’s established clinical application.

Q: Can people with kidney problems safely use Promid?

A: Official safety warnings note that specific caution should be used when prescribing Promid to populations with pre-existing renal impairment (kidney problems). Monitoring is often a consideration for patients with this condition due to a potentially altered risk profile.

Q: Can people with a history of heart issues take Promid?

A: Long-term clinical research monitored for adverse events in participants who had underlying chronic conditions, including mild heart conditions. This was done to assess the drug’s overall tolerability within these groups.

Q: How quickly should I expect to feel a difference after starting Promid?

A: Single-dose clinical trials explored the timing and intensity of the initial reported changes in symptoms after participants took the medicine. Trials explored the timing of the initial reported change in symptoms after a single dose.

Q: What's the typical time frame to see the full effect of Promid?

A: Longer-term research studies that tracked changes in health outcomes were often extended, with some lasting 6 to 12 months or longer. This suggests that observing the full effects may require a sustained period of use.

How should Promid be stored and disposed of?

How to Store and Dispose of Promid

Promid must be stored according to official regulatory conditions to maintain its effectiveness and stability.

Storage Requirements

Condition Requirement
Temperature Store below 30 C (86 F); do not refrigerate or freeze.
Protection Protect from light and moisture.
Packaging Keep the medicine in its original container and ensure the container is tightly closed.
Child Safety Keep out of the sight and reach of children.
Stability Do not use the product after the expiry date printed on the package.

Disposal Instructions

Unused or expired Promid must be disposed of according to local pharmaceutical regulations. The product must not be discarded in household trash or poured down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Promid found in:

A-Z Index: